The News
Qosmos receives a first round of financing from Sofinnova Partners
12/07/2004
The French company offers an innovative solution to optimizing IP networks
Paris, 12 July 2004 – Sofinnova Partners has announced a first round of financing of 2 million euros for Qosmos, a French company specialized in auditing and optimizing IP networks. Picardie Avenir, a French regional investment fund, contributed 100, 000 euros to the round.
Created in 2000 with the assistance of scientists from LIP6, a research division of the Université Pierre et Marie Curie in Paris, and of the CNRS (French National Center for Scientific Research), Qosmos has developed its own technology for capturing and analyzing network flows and storing them in a personalized data bank, which can be consulted immediately or at a later time. This diagnostic tool, based on the most advanced technology in recognition and application intelligence, makes it possible to carry on a complete analysis, on a real-time basis, of everything circulating on the network. Each application, and the quality of service delivered, can thus be thoroughly evaluated.
Qosmos’s products may also play an active role in fixing priorities among applications, for example ERP, voice/video over IP or thin client infrastructure. This allows companies better control over their telecommunications budget, while improving the security and the quality of service actually delivered to the end-user.
Qosmos sees what others do not. The company’s on-the-fly semantic analysis approach is radically different from other solutions on the market, which involve storing a great amount of data and using supervision tools to exploit them afterwards. Qosmos’s real-time auditing means that only the information gathered and computed for a particular search is stored. Qosmos’s products not only analyze the network lower layers but also the more complex languages at the upper application layer.
Traffic Analyzer 1, one of the company’s star products, performs an immediate audit on a precise point of search and instantly provides detailed information on the nature, the volume and the response time of the applications on the network. Thanks to this information, the network administrator can use Traffic Designer-1, another product by Qosmos, to intervene on the network and to control the priorities, reduce or even block certain application flows.
Qosmos’s products have already been adopted by Nortel, France Télécom, the Caisses d’Epargne banking group and Ipanema Technologies, among others.
“We were impressed by the original and patent-protected technology offered by Qosmos, which represents a real advance in network auditing,” said Olivier Protard, Sofinnova Partners’ Managing Partner. « The rapid proliferation of Internet computing has put new strains on IP traffic management. Qosmos brings an innovative solution to the area of application intelligence.”
“We are very pleased to receive this first round of financing from Sofinnova Partners, which will allow us to speed up our research activities, develop new products, and target an international clientele,” said Yvon Leroy, Qosmos’s President.
For furthur information, please contact:
Sofinnova :
Madeleine Resener
Media relations
Telephone :
+33 (0) 1 53 05 41 00
+33 (0) 6 20 41 39 82
mresener@sofinnova.fr
Qosmos :
Yvon Leroy
President
Telephone :
+33 (0)1 44 89 46 00
Yvon.leroy@qosmos.fr
Jean-Marc Minière
Sales and marketing director
Telephone :
+33 (0) 1 44 89 46 05
jean-marc.miniere@qosmos.fr
About Sofinnova Partners:
Founded in Paris in 1972, Sofinnova Partners is one of Europe's leading independent venture capital firms. With 500 million euros under management, Sofinnova Partners invests in start-ups and early-stage companies in information technology and life sciences. Its investment strategy is based on two principles: Investing early in projects with a high potential; and
acting as lead or co-lead investor. Sofinnova's investment team consists of 10 professionals, all recognized experts in their field, who bring valuable market insight and technical expertise to Sofinnova's portfolio companies. Since the firm is increasingly solicited for financing pan-European projects, half of Sofinnova's most recent fund, Sofinnova Capital IV, will be invested outside France.
About Qosmos :
Located in Paris, Qosmos (http://www.qosmos.fr/) provides an innovative platform for auditing and managing IP networks. Qosmos’s solutions enable businesses to control and optimize the performance and security of their critical networked applications such as ERP, Voice/video over IP and thin client infrastructures. Based on the most advanced technologies in application intelligence, Qosmos’s solutions perform real-time recognition, classification and priority management of all application traffic over IP networks. Created in 2000 with the assistance of scientists from LIP6, a research division of Université Pierre et Marie Curie in Paris, and CNRS (French National Center for Scientific Research), Qosmos enjoys a permanent technology watch for a rapid integration of the latest state-of-the-arts evolutions.
2004
- 21/01/2004
- 21/01/2004
- 28/01/2004
- 26/01/2004
- 26/01/2004
- 29/01/2004
-
29/01/2004
Sofinnova Partners investit dans InfraWorlds, société à fort potentiel
- 09/02/2004
- 09/02/2004
- 16/02/2004
- 25/02/2004
- 25/02/2004
-
26/02/2004
Esmertec gains a worldwide leadership role in fast growing mobile Java™ markets
- 24/02/2004
- 24/02/2004
-
23/02/2004
SOFINNOVA earmarks €85 million to accelerate activity in European wireless market
- 04/03/2004
- 08/03/2004
- 17/03/2004
- 08/03/2004
- 18/03/2004
- 29/03/2004
- 29/03/2004
-
07/04/2004
Esmertec™ provides Time Warner Cable with JVM solution for the OCAP Market
- 06/04/2004
- 06/04/2004
- 20/04/2004
- 21/04/2004
- 27/04/2004
-
03/05/2004
Vidiom Systems Selects Esmertec™ to provide the JVM solution for its OCAP Products
-
05/05/2004
Georges Haas, Ph.D., Joins Ingenium’s Supervisory Board Munich, Germany, May 5, 2004
-
10/05/2004
Faust raises 16 million euros to further develop its product candidates
-
10/05/2004
Faust Pharmaceuticals lève 16 M d’euros pour développer ses produits en clinique
-
03/05/2004
Saegis Pharmaceuticals Begins Phase II Clinical Trial of SGS742 for Alzheimer’s Disease
- 28/04/2004
-
12/05/2004
Ingenium Acquires Pivotal Patents for INGENOtypingTM Platform
-
17/05/2004
Addex Pharmaceuticals Completes Largest ever European Biotech Series B Fund Raising
- 19/05/2004
- 25/05/2004
- 10/06/2004
- 07/06/2004
- 22/06/2004
- 07/06/2004
- 14/06/2004
-
14/06/2004
TRISENOX® Produces Hematologic Responses in 27 Percent of MDS Patients
-
22/06/2004
Esmertec to demonstrate new breakthrough Java™ Solution – Jbed™ Advanced during JavaOne 2004
- 22/06/2004
-
28/06/2004
Esmertec’s Java™ Virtual Machine (JVM) solution for mobile phones is selected by Panasonic
- 01/07/2004
- 23/06/2004
-
06/07/2004
Atomz Named to Second-Annual AlwaysOnTM List of Top 100 Private Companies
- 30/06/2004
-
12/07/2004
Qosmos reçoit un premier tour de financement de Sofinnova Partners
-
12/07/2004
Qosmos receives a first round of financing from Sofinnova Partners
-
07/07/2004
Esmertec ouvre un centre d'assistance clientèle et de test à Taipei (Taiwan)
-
07/07/2004
Esmertec is opening Customer Support and Testing Centre in Taipei, Taiwan
-
19/07/2004
Ablynx and Procter&Gamble form nanobody drug discovery and development partnership
- 22/07/2004
- 20/07/2004
-
22/07/2004
Esmertec welcomes Michel Bon, Former CEO and Chairman of France Telecom, to its Board
-
26/07/2004
Cell Therapeutics, Inc. Completes Enrollment in Third Pivotal Trial of XYOTAX™ in Lung Cancer
- 26/07/2004
-
28/07/2004
Diatos Elected Among the Top 15 Emerging Biotech Companies of 2004
-
30/07/2004
6WIND emporers customers and partners with a further commitment to quality
-
02/08/2004
Les plus hautes performances Java jamais atteintes sur cœur de MIPS32 24Kc
-
02/08/2004
Highest Java™ Performance Achieved by the MIPS32® 24Kc™ Core
- 27/07/2004
- 27/07/2004
- 16/08/2004
-
09/08/2004
"Euronext n'a pas la place financière qu'il mérite" Jean-Bernard Schmidt - Les Echos 9 Août 2004 -
-
30/08/2004
Tony Reis, l’ancien CEO de Swisscom, rejoint le Conseil d’Administration d’Esmertec
-
30/08/2004
Tony Reis, Former CEO of Swisscom, joins Esmertec’s Board of Directors
-
24/08/2004
Enfora partners with Esmertec to enable wireless Java technology in their GSM/GPRS OEM devices
-
24/08/2004
Enfora se rapproche d’Esmertec pour intégrer la technologie Java dans ses terminaux GSM/GPRS
-
16/08/2004
Intransa secures twenty five million dollars in series D funding
-
06/09/2004
Sensitive Object secures 2 million € Series A financing round from Sofinnova Partners
- 06/09/2004
-
08/09/2004
Oxxius reçoit un premier financement de 2,4 millions d'euros de Sofinnova Partners
-
14/09/2004
Le Dr Ulrich Schumacher rejoint le Conseil d’Administration d’Esmertec
-
08/09/2004
Oxxius receives 2.4 million euros from Sofinnova Partners in first round of financing
-
14/09/2004
Dr. Ulrich Schumacher joins Esmertec as a Member of the Board of Directors
- 20/09/2004
- 23/09/2004
-
23/09/2004
France Telecom selects Esmertec as technology partner for its embedded Java platforms
- 30/09/2004
- 30/09/2004
-
26/10/2004
Esmertec lève CHF 23.5 Millions par le biais d’obligations convertibles
-
26/10/2004
Esmertec raises CHF 23.5 Million from convertible note to fund growth
-
26/10/2004
Intransa annouces IP5500 - The industry's next-generation modular IP san solution for the mid-market
-
10/11/2004
Varioptic Selected Most Innovative Company of the Year for Its Liquid Lenses
-
10/11/2004
Varioptic élue Entreprise Innovante de l’année pour ses lentilles liquides
- 18/11/2004
-
18/11/2004
Esmertec Establishes Strategic Relationship with Mitsui & Co.
- 17/11/2004
-
22/11/2004
Ablynx appoints Edwin Moses as chairman of the board of directors
-
23/11/2004
Sendo choisit la solution Java d’Esmertec’s pour ses téléphones mobiles
-
23/11/2004
Sendo has chosen Esmertec’s Java solution for its mobile phones
- 23/11/2004
- 06/12/2004
-
05/12/2004
TRISENOX® Produces Hematologic Responses in 30 Percent of Patients with Higher-Risk MDS
-
09/12/2004
Esmertec to Integrate Hybrid’s OpenGL ES based Graphics Solutions into its Jbed Solution
-
16/12/2004
Diatos moves its lead drug, DTS-201, toward clinical trials in Europe
- 23/12/2004
- 16/12/2004
- 01/11/2004
-
16/12/2004
Esmertec to further secure mobile Java content with SATSA-based implementation from Gemplus
-
16/12/2004
Esmertec sécurise les contenus des mobiles Java avec l’implémentation SATSA de Gemplus